RxDoctor Payments Data

Amanda Foti, PA

Physician Assistant · East Haven, CTNPI 1447652193

Payments from drug & device makers

$1,506in general payments, 2019–2025

Across 95 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$433
  • GSK$134
  • Novo Nordisk$123
  • Lilly USA, LLC$101
  • Merck$73
  • Teva Pharmaceuticals USA, Inc.$67
  • plus $575 from 21 others

What the payments were for

  • Food & beverage$1,506100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,506 in reported general payments places this provider in the 85th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$47,079
Medicare patients
98
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide42$44,899
FarxigaDapagliflozin Propanediol26$35,041
OzempicSemaglutide22$21,492
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,310
LinzessLinaclotide11$15,853
EliquisApixaban16$13,940
SymbicortBudesonide/Formoterol Fumarate32$9,647
Spiriva RespimatTiotropium Bromide16$8,880
Breo ElliptaFluticasone/Vilanterol16$8,130
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl42$4,609
ShingrixVaricella-Zoster Ge/As01b/Pf13$2,779
Rosuvastatin Calcium160$1,779
Levothyroxine Sodium114$1,771
Nebivolol Hcl17$1,659
Ventolin HfaAlbuterol Sulfate22$1,277

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$101$44,89942 claims
AstraZenecaFarxiga, Symbicort$50$44,68758 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$134$27,22051 claims
Novo NordiskOzempic$123$21,49222 claims
AbbVieLinzess$433$15,85311 claims
PfizerEliquis$41$13,94016 claims
Boehringer IngelheimSpiriva Respimat$50$8,88016 claims
Scilex Pharmaceuticals Inc.Colchicine$19$20615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in East Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →